Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vertex Pharmaceuticals Larger Than S&P 500 Component Noble Corp
Forbes
Saturday, December 15, 2012 - 11:23am
tags:
Vertex Pharmaceuticals
Gilead Sciences' Stock Dividend And What's Behind It
Seeking Alpha
Saturday, December 15, 2012 - 11:23am
tags:
Gilead Sciences
Grab This Deal Even Lower Than CEO and President Lichtinger Did
Forbes
Saturday, December 15, 2012 - 11:22am
tags:
Optimer Pharmaceuticals
CEL-SCI Corporation Announces Fiscal 2012 Financial Results
Yahoo/BusinessWire
Saturday, December 15, 2012 - 11:21am
tags:
Cel-Sci, earnings
2 Healthcare Stocks To Consider In The Wake Of 30% Dividend Hikes
Seeking Alpha
Saturday, December 15, 2012 - 11:20am
tags:
Amgen, Caremark
3 Investment Lessons From Biotech's 2012 Failures
Motley Fool
Saturday, December 15, 2012 - 11:19am
tags:
Will Kalydeco Push Vertex Higher?
Motley Fool
Saturday, December 15, 2012 - 11:18am
tags:
Kalydeco, cystic fibrosis, Vertex Pharmaceuticals
FDA Advisory Meeting Leaves Zogenix Stock In Tatters
Seeking Alpha
Friday, December 14, 2012 - 12:34pm
tags:
FDA, Zogenix, Zohydro
Roche looks to earn even more from Perjeta with EU nod
Fierce Pharma
Friday, December 14, 2012 - 12:32pm
tags:
Roche, Perjeta, Europe, breast cancer
Ariad Wins Approval for Drug to Treat Rare Leukemias, FDA Says
Bloomberg
Friday, December 14, 2012 - 12:31pm
tags:
Ariad Pharmaceuticals, FDA, chronic myeloid leukemia, Iclusig
Amicus Soon To Release New Phase III Data
Seeking Alpha
Friday, December 14, 2012 - 12:30pm
tags:
Amicus, AT1001, Amigal, Migalastat HCl, Fabry's disease
Lpath Announces Pricing of Public Offering of Common Stock
Yahoo
Friday, December 14, 2012 - 12:28pm
tags:
Lpath, stock offering
4 Reasons Amarin Will Keep Tanking
Seeking Alpha
Friday, December 14, 2012 - 11:52am
tags:
Amarin
EU panel recommends approval of Alexza's Adasuve
Yahoo/AP
Friday, December 14, 2012 - 11:51am
tags:
Europe, Alexza, Adasuve, schizophrenia
Lundbeck’s Anti-Alcoholism Pill Wins EU Regulatory Nod
Bloomberg
Friday, December 14, 2012 - 11:50am
tags:
Lundbeck, alcoholism, Selincro, Europe
Pfizer/Ligand get PDUFA date for menopause combo
Pharma Times, UK
Friday, December 14, 2012 - 11:49am
tags:
Pfizer, Ligand, menopause, bazedoxifene/conjugated estrogens
Cambridge biotech Vaxxas teams with Merck
Boston Herald, MA
Friday, December 14, 2012 - 11:48am
tags:
Vaxxas, Merck, vaccines, Nanopatch
Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO
Yahoo/Fly on the Wall
Friday, December 14, 2012 - 11:47am
tags:
Genzyme, Isis Pharmaceuticals, Kynamro, CHMP, Homozygous Familial Hypercholesterolemia
AbbVie's Outlook Highly Dependent on Well-Positioned Humira
Yahoo/Morningstar
Friday, December 14, 2012 - 11:42am
tags:
Humira, AbbVie
Pfizer to launch animal-health unit IPO in early 2013, may raise $4 billion
Reuters
Friday, December 14, 2012 - 11:41am
tags:
Pfizer, IPO, animal health, Zoetis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.